Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Cancer Research|June 1, 2014
Loss of LRIG1 locus increases risk of early and late relapse of stage I/II breast cancerPatricia A Thompson, Ingrid Ljuslinder, Spyros Tsavachidis, et al.
Cancers|November 24, 2020
A Detailed Flow Cytometric Analysis of Immune Activity Profiles in Molecular Subtypes of Colorectal CancerXingru Li, Agnes Ling, Therese G Kellgren, et al.
Scientific Reports|September 18, 2020
Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancerThyra Löwenmark, Anna Löfgren-Burström, Carl Zingmark, et al.
British Journal of Cancer|December 1, 2023
Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer - possible implications for immunotherapySofia Edin, Björn Gylling, Xingru Li, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 25, 2019
PET/MRI and PET/CT hybrid imaging of rectal cancer - description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) studyMiriam K Rutegård, Malin Båtsman, Jan Axelsson, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|November 1, 2020
Rectal cancer: a methodological approach to matching PET/MRI to histopathologyMiriam K Rutegård, Malin Båtsman, Lennart Blomqvist, et al.
European Radiology|January 21, 2025
Evaluation of MRI characterisation of histopathologically matched lymph nodes and other mesorectal nodal structures in rectal cancerMiriam Kheira Rutegård, Malin Båtsman, Lennart Blomqvist, et al.
Cancer Immunology, Immunotherapy : CII|March 18, 2022
Parvimonas micra is associated with tumour immune profiles in molecular subtypes of colorectal cancerThyra Löwenmark, Xingru Li, Anna Löfgren-Burström, et al.
Trials|August 10, 2014
Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trialRoger Olofsson, Lars Ny, Malin Sternby Eilard, et al.
BMC Cancer|May 4, 2019
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label studyHenrik Jespersen, Roger Olofsson Bagge, Gustav Ullenhag, et al.
Pageof 6